EMD Serono Partners with Trump Admin on IVF Access Program

EMD Serono and the Trump administration have announced a partnership to expand access to in vitro fertilization (IVF) therapies for Americans experiencing fertility challenges. The healthcare company will offer its portfolio of IVF medications at significantly reduced prices through direct-to-consumer sales, providing an 84% discount off list prices when patients use all three of the company's primary fertility medications. The agreement aligns with a White House Executive Order focused on increasing affordable access to fertility treatments.